Multiple Vulnerabilities in my little forum
|Product:||my little forum|
|Vulnerable Versions:||2.3.3 and probably prior|
|Advisory Publication:||January 14, 2015 [without technical details]|
|Vendor Notification:||January 14, 2015|
|Vendor Fix:||February 8, 2015|
|Public Disclosure:||February 11, 2015|
|Latest Update:||February 9, 2015|
|Vulnerability Type:||SQL Injection [CWE-89]|
Cross-Site Scripting [CWE-79]
|CVSSv2 Base Scores:||6.5 (AV:N/AC:L/Au:S/C:P/I:P/A:P)|
|Solution Status:||Fixed by Vendor|
|Discovered and Provided:||High-Tech Bridge Security Research Lab|
High-Tech Bridge Security Research Lab discovered multiple vulnerabilities in my little forum, which can be exploited to perform SQL Injection and Cross-Site Scripting (XSS) attacks. The SQL injection vulnerabilities have medium risk assigned as they can be exploited under administrator account or via XSRF vector.
|Update to my little forum 2.3.4|
| High-Tech Bridge Advisory HTB23248 - https://www.immuniweb.com/advisory/HTB23248 - Multiple Vulnerabilities in my little forum.|
 my little forum - http://mylittleforum.net/ - my little forum is a simple PHP and MySQL based internet forum that displays the messages in classical threaded view (tree structure).
 Common Vulnerabilities and Exposures (CVE) - http://cve.mitre.org/ - international in scope and free for public use, CVE® is a dictionary of publicly known information security vulnerabilities and exposures.
 Common Weakness Enumeration (CWE) - http://cwe.mitre.org - targeted to developers and security practitioners, CWE is a formal list of software weakness types.
 ImmuniWeb® - Leveraging the power of machine-learning and genius of human brain to deliver the most advanced web application security and penetration testing.
 ImmuniWeb® SSLScan - Test your servers for security and compliance with PCI DSS, HIPAA and NIST.
Please feel free to send us any additional information related to this Advisory, such as vulnerable versions, additional exploitation details and conditions, patches and other relevant details.